Two Sigma Investments, LP Moderna, Inc. Call Options Transaction History

Two Sigma Investments, LP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $8.81 Million - $16.4 Million	-69,700 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $677,460 - $1.11 Million	3,000 Added 4.5%	69,700 $17.7 Million
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $4.3 Million - $9.4 Million	-19,400 Reduced 22.53%	66,700 $25.7 Million
Q2 2021 Aug 16, 2021	SELL	$129.91 - $234.98 $10.8 Million - $19.5 Million	-82,900 Reduced 49.05%	86,100 $20.2 Million
Q1 2021 May 17, 2021	BUY	$109.18 - $185.98 $18.5 Million - $31.4 Million	169,000 New	169,000 $22.1 Million

913

236M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.